Urological cancer. The benefits of intermittent androgen-deprivation therapy.

Mitin, Timur

Urological cancer. The benefits of intermittent androgen-deprivation therapy. [electronic resource] - Nature reviews. Clinical oncology Dec 2012 - 672-3 p. digital

Publication Type: Journal Article; Comment

1759-4782

10.1038/nrclinonc.2012.201 doi


Androgen Antagonists--administration & dosage
Humans
Male
Prostatic Neoplasms--drug therapy